Angiogenesis

Angiogenesis is the formation and remodelling of new blood vessels and capillaries from growth of pre-existing blood vessels. It normally occurs during wound healing and embryonic development, but is also required for tumour growth and metastasis in cancer.

3 个项目

每页

设置升序顺序
  1. Sorafenib Tosylate (Nexavar)

    Catalog No. A10001
    Quick View
    Raf 抑制剂
    Sorafenib Tosylate (Nexavar)是几种酪氨酸蛋白激酶(VEGFR和PDGFR)和RAF/MEK/ERK级联抑制剂的新型小分子抑制剂,Raf-1,wt BRAF和V599E突变型BRAF的IC50为6、22、38 nM。 了解更多
  2. Raf265 derivative

    Catalog No. A10774
    Quick View
    RAF/VEGFR 抑制剂
    Raf265 derivative是Raf265的衍生物,Raf265是一种口服,高度选择性的RAF和VEGFR激酶抑制剂,IC50为5至10μM。 了解更多
  3. RAF265 (CHIR-265)

    Catalog No. A10773
    Quick View
    RAF/VEGFR 抑制剂
    RAF265 (CHIR-265)是一种口服,高度选择性的RAF和VEGFR激酶抑制剂,可控制或正常化VEGFR-2,同时抑制B-raf和c-Raf突变以预防癌症。 了解更多

3 个项目

每页

设置升序顺序
Rewards